2,173
Views
41
CrossRef citations to date
0
Altmetric
Review

Global prevalence of antibiotic resistance in blood-isolated Enterococcus faecalis and Enterococcus faecium: a systematic review and meta-analysis

, , &
Pages 2713-2725 | Published online: 02 Sep 2019

References

  • Laxminarayan R, Matsoso P, Pant S, et al. Access to effective antimicrobials: a worldwide challenge. Lancet. 2016;387(10014):168–175. doi:10.1016/S0140-6736(15)00474-226603918
  • Holmes AH, Moore LS, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387(10014):176–187. doi:10.1016/S0140-6736(15)00473-026603922
  • Holmberg SD, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev Infect Dis. 1987;9(6):1065–1078.3321356
  • Planta MB. The role of poverty in antimicrobial resistance. J Am Board Fam Med. 2007;20(6):533–539. doi:10.3122/jabfm.2007.06.07001917954860
  • Vincent J-L. Nosocomial infections in adult intensive-care units. lancet. 2003;361(9374):2068–2077. doi:10.1016/S0140-6736(03)13644-612814731
  • Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. Jama. 2003;290(14):1868–1874. doi:10.1001/jama.290.14.186814532315
  • Agaba P, Tumukunde J, Tindimwebwa J, Kwizera A. Nosocomial bacterial infections and their antimicrobial susceptibility patterns among patients in Ugandan intensive care units: a cross sectional study. BMC Res Notes. 2017;10(1):349. doi:10.1186/s13104-017-2695-528754148
  • Brandl K, Plitas G, Mihu CN, et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature. 2008;455(7214):804. doi:10.1038/nature0727018724361
  • Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci. 2008;105(39):15064–15069. doi:10.1073/pnas.080312410518806221
  • Ruiz-Garbajosa P, de Regt M, Bonten M, et al. High-density fecal Enterococcus faecium colonization in hospitalized patients is associated with the presence of the polyclonal subcluster CC17. Eur J Clin Microbiol Infect Dis. 2012;31(4):519–522. doi:10.1007/s10096-011-1342-721789603
  • Tedim AP, Ruiz-Garbajosa P, Corander J, et al. Population biology of intestinal Enterococcus isolates from hospitalized and nonhospitalized individuals in different age groups. Appl Environ Microbiol. 2015;81(5):1820–1831. doi:10.1128/AEM.03661-1425548052
  • Ubeda C, Taur Y, Jenq RR, et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest. 2010;120(12):4332–4341. doi:10.1172/JCI4391821099116
  • MacCallum WG, Hastings TW. A case of acute endocarditis caused by Micrococcus zymogenes (nov. spec.), with a description of the microorganism. J Exp Med. 1899;4(5–6):521–534. doi:10.1084/jem.4.5-6.521
  • Olawale KO, Fadiora SO, Taiwo SS. Prevalence of hospital acquired enterococci infections in two primary-care hospitals in Osogbo, Southwestern Nigeria. Afr J Infect Dis. 2011;5:2. doi:10.4314/ajid.v5i2.66513
  • McBride S, Upton A, Roberts S. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia—a five-year retrospective review. Eur J Clin Microbiol Infect Dis. 2010;29(1):107–114. doi:10.1007/s10096-009-0830-519916034
  • Vergis EN, Hayden MK, Chow JW, et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia: a prospective multicenter study. Ann Intern Med. 2001;135(7):484–492. doi:10.7326/0003-4819-135-7-200110020-0000711578151
  • Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis. 2007;58(2):163–170. doi:10.1016/j.diagmicrobio.2006.12.02217368801
  • Hidron AI, Edwards JR, Patel J, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol. 2008;29(11):996–1011. doi:10.1086/59186118947320
  • Reik R, Tenover FC, Klein E, McDonald LC. The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004. Diagn Microbiol Infect Dis. 2008;62(1):81–85. doi:10.1016/j.diagmicrobio.2008.04.01318508225
  • Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309–317. doi:10.1086/42194615306996
  • van Harten RM, Willems RJ, Martin NI, Hendrickx AP. Multidrug-resistant enterococcal infections: new compounds, novel antimicrobial therapies? Trends Microbiol. 2017;25(6):467–479. doi:10.1016/j.tim.2017.01.00428209400
  • Chlebicki MP, Kurup A. Vancomycin-resistant Enterococcus: a review from a Singapore perspective. Ann Acad Med Singapore. 2008;37(10):861–869.19037521
  • de Bruin MA, Riley LW. Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review. BMC Infect Dis. 2007;7(1):24. doi:10.1186/1471-2334-7-8917425800
  • Ho C, Lau A, Cimon K, Farrah K, Gardam M. Screening, isolation, and decolonization strategies for vancomycin-resistant enterococci or extended spectrum beta-lactamase producing organisms: a systematic review of the clinical evidence and health services impact. europepmc. 2012. doi:10.1094/PDIS-11-11-0999-PDN
  • Shenoy ES, Paras ML, Noubary F, Walensky RP, Hooper DC. Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review. BMC Infect Dis. 2014;14(1):177. doi:10.1186/1471-2334-14-17724678646
  • Ulrich N, Vonberg R-P, Gastmeier P. Outbreaks caused by vancomycin-resistant Enterococcus faecium in hematology and oncology departments: a systematic review. Heliyon. 2017;3(12):e00473. doi:10.1016/j.heliyon.2017.e0047329322099
  • Van Tulder M, Furlan A, Bombardier C, Bouter L; Group EBotCCBR. Updated method guidelines for systematic reviews in the cochrane collaboration back review group. Spine (Phila Pa 1976). 2003;28(12):1290–1299. doi:10.1097/01.BRS.0000065484.95996.AF12811274
  • Houri H, Pormohammad A, Riahi SM, et al. Acute bacterial meningitis in Iran: systematic review and meta-analysis. PLoS One. 2017;12(2):e0169617. doi:10.1371/journal.pone.016961728170400
  • Pormohammad A, Seyed-Mohammad R, Nasiri MJ, et al. Diagnostic test accuracy of adenosine deaminase for tuberculous meningitis: a systematic review and meta-analysis. J Infect. 2017. doi:10.1016/j.jinf.2017.02.012
  • Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W-65–W-94. doi:10.7326/0003-4819-151-4-200908180-00136
  • Munn Z, Moola S, Riitano D, Lisy K. The development of a critical appraisal tool for use in systematic reviews: addressing questions of prevalence. Int J Health Policy Manag. 2014;3:123. doi:10.15171/ijhpm.2014.7125197676
  • Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies. J Natl Cancer Inst. 1959;22(4):719–748.13655060
  • Arias CA, Murray BE. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol. 2012;10(4):266. doi:10.1038/nrmicro276122421879
  • Vankerckhoven V, Van Autgaerden T, Vael C, et al. Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium. J Clin Microbiol. 2004;42(10):4473–4479. doi:10.1128/JCM.42.10.4473-4479.200415472296
  • Billington E, Phang S, Gregson D, et al. Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: a population-based study. Int J Infect Dis. 2014;26:76–82. doi:10.1016/j.ijid.2014.02.01224813873
  • Caballero-Granado F, Becerril B, Cuberos L, Bernabeu M, Cisneros J, Pachon J. Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia. Clin Infect Dis. 2001;32(4):587–594. doi:10.1086/31871711181122
  • DiazGranados CA, Zimmer SM, Mitchel K, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis. 2005;41(3):327–333. doi:10.1086/43090916007529
  • Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis. 1995;20(5):1126–1133. doi:10.1093/clinids/20.5.11267619987
  • Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis. 1995;20(2):296–301. doi:10.1093/clinids/20.2.2967742433
  • Patterson JE, Sweeney AH, Simms M, et al. An analysis of 110 serious enterococcal infections. Epidemiology, antibiotic susceptibility, and outcome. Medicine 1995;74(4):191–200.7623654
  • Linden P. Can enterococcal infections initiate sepsis syndrome? Curr Infect Dis Rep. 2003;5(5):372–378.13678566
  • Jia W, Li G, Wang W. Prevalence and antimicrobial resistance of Enterococcus species: a hospital-based study in China. Int J Environ Res Public Health. 2014;11(3):3424–3442. doi:10.3390/ijerph11030342424662964
  • Hershberger E, Donabedian S, Konstantinou K, Zervos MJ, Eliopoulos GM. Quinupristin-dalfopristin resistance in gram-positive bacteria: mechanism of resistance and epidemiology. Clin Infect Dis. 2004;38(1):92–98. doi:10.1086/38012514679454
  • Dobbs TE, Patel M, Waites KB, Moser SA, Stamm AM, Hoesley CJ. Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center. J Clin Microbiol. 2006;44(9):3368–3370. doi:10.1128/JCM.00850-0616954275
  • Kristich CJ, Rice LB, Arias CA. Enterococcal infection—treatment and antibiotic resistance. Boston: Massachusetts Eye and Ear Infirmary; 2014.
  • Huycke MM, Sahm DF, Gilmore MS. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis. 1998;4(2):239. doi:10.3201/eid0402.9802119621194
  • Ike Y, Hashimoto H, Clewell D. High incidence of hemolysin production by Enterococcus (Streptococcus) faecalis strains associated with human parenteral infections. J Clin Microbiol. 1987;25(8):1524–1528.3114322
  • Jett B, Jensen H, Nordquist R, Gilmore M. Contribution of the pAD1-encoded cytolysin to the severity of experimental Enterococcus faecalis endophthalmitis. Infect Immun. 1992;60(6):2445–2452.1587612
  • Arce JS, Gainza EC, Brusola AG, Estévez RO, Canton E, Gobernado M. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus. Rev Esp Quimioterap. 2006;19(3): 252–47.
  • Beitdaghar M, Ahmadrajabi R, Karmostaji A, Saffari F. In vitro activity of linezolid alone and combined with other antibiotics against clinical enterococcal isolates. Wien Med Wochenschr. 2019; 169:215.
  • Gales AC, Sader HS, Ribeiro J, Zoccoli C, Barth A, Pignatari AC. Antimicrobial susceptibility of gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY program (2005-2008). Braz J Infect Dis. 2009;13(2):90–98.20140350
  • Moellering RC. Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med. 2003;138(2):135–142. doi:10.7326/0003-4819-138-2-200301210-0001512529096
  • Maina D, Omuse G, Revathi G, Adam RD. Spectrum of microbial diseases and resistance patterns at a private teaching hospital in Kenya: implications for clinical practice. PLoS One. 2016;11(1):e0147659. doi:10.1371/journal.pone.014765926807811
  • Årdal C, Outterson K, Hoffman SJ, et al. International cooperation to improve access to and sustain effectiveness of antimicrobials. Lancet. 2016;387(10015):296–307. doi:10.1016/S0140-6736(15)00470-526603920
  • Founou LL, Founou RC, Essack SY. Antibiotic resistance in the food chain: a developing country-perspective. Front Microbiol. 2016;7:1881. doi:10.3389/fmicb.2016.0188127933044
  • Del Rosario BP, Aquino AP, Tidon AG, Gerpacio RV. Livestock Sector Training Needs Assessment Report for Southeast Asia, China and Papua New Guinea. 2008.
  • Hammerum A. Enterococci of animal origin and their significance for public health. Clin Microbiol Infect. 2012;18(7):619–625. doi:10.1111/j.1469-0691.2012.03829.x22487203